Kookmin Bio

Kookmin Bio is a South Korean biotechnology company focused on developing microbiome-derived therapeutics and functional health ingredients. Established as a spin-off from Kookmin University, the company leverages specialized research into soybean-derived postbiotics and gut microbiota to address age-related and metabolic conditions. Their primary R&D efforts target sarcopenia, obesity, and inflammatory diseases through the modulation of the human microbiome. In addition to its pharmaceutical pipeline, Kookmin Bio commercializes high-value functional food products based on its proprietary fermentation and extraction technologies. The company aims to bridge the gap between academic research and clinical application in the field of personalized microbiome medicine.